Knockdown or impairment of the redox or DNA repair function of APE1 by small molecules inhibitors inhibits tumor cell proliferation and sensitizes cells to a variety of chemotherapeutic agents [24, 27–29]. This evidence concerns the gene APEX1 and neoplasm.